| Do you have any exams coming up? http://www.deltanineplus.com/goodrx-voltaren-gel-9491.pdf goodrx voltaren gel One of the more worrisome challenges facing Merck is slowing sales growth for its biggest franchise, the diabetes drugs Januvia and Janumet which have combined annual sales of $6 billion. They have been Merck's growth engine over the past three years but are stalling due to similar rival drugs and newer classes of diabetes treatments.
|